Hypertension and Arrhythmias in CLL Patients Treated with BTK Inhibitors

Enrolling by invitationOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Chronic Lymphocytic LeukemiaAtrial FibrillationHypertensionCardiotoxicity

Interventions

OTHER

no intervention

Trial Locations (1)

Abramson Cancer Center at University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

Abramson Cancer Center at Penn Medicine

OTHER